We are a diverse, passionate team of doctors, scientists, researchers, growers, educators, and advocates who came together with the goal of increasing access to safe, high quality cannabis for medical patients and recreational consumers. Our four facilities are located coast-to-coast across Canada in Delta and Langley, British Columbia; Atholville, New Brunswick; and Stellarton, Nova Scotia. Zenabis currently owns 3.5 million square feet of facility space that can, upon full conversion, be dedicated to cannabis production.
Zenabis owns 660,000 square feet of high quality indoor facility space, as well as 2.1 million square feet of greenhouse space that will be dedicated to cannabis production once fully built-out. Our operations are strategically located on Canada’s East and West coasts, facilitating domestic distribution as well as international export (pending regulatory approval). These facilities, if fully converted for cannabis production, would have the design capacity to yield 479,300kg of dried cannabis annually. An additional 700,000 square feet of greenhouse space that was acquired after a reverse-takeover of Bevo Agro is used to continue an existing plant propagation business, and this will be converted to cannabis production at such a time that is beneficial to the strategic position of the company. The Zenabis brand name is used among the medical market, while Namaste and Blazery service the recreational market.
The management team at Zenabis has significant experience in agriculture, technology, pharmaceutical sales, consumer packaged goods, international distribution, brand marketing, and finance. Our corporate leadership is backed by the expertise of individuals in the roles of Chief Operating Officer, Chief Growing Officer, Chief Science Officer, and Chief Medical Officer.
Zenabis’ vision is to become one of the largest and most efficient licensed producers of medical and adult-use recreational cannabis, with a variety of value-add cannabis products. One of its key differentiators is its deep growing ability, which allows Zenabis to deliver consistent cultivation results that have exceeded original design capacity estimates.
Zenabis’ marketing strategy is built on offering consumers high-quality cannabis products combined with tailor-made brands that cater to medical and adult-use recreational customer bases. In addition, Zenabis expects to drive long-term growth through innovation and technology. The Company plans to implement its strategy via additional investment in research and development as well as partnering with other leading organizations.